UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q6UXP9 (YO001_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein UNQ9370/PRO34162; | |
Q13442 (HAP28_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 28 kDa heat- and acid-stable phosphoprotein; PDGF-associated protein; PDGFA-associated protein 1; | |
Q9NX38 (ABITM_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein Abitram; Actin-binding transcription modulator; Protein Simiate; | |
Q96N68 (CR015_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein C18orf15; | |
Q9ULC4 (MCTS1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Malignant T-cell-amplified sequence 1; Multiple copies T-cell malignancies; | |
A0A3B3IRV3 (MCTS2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Malignant T-cell-amplified sequence 2; | |
P41271 (NBL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuroblastoma suppressor of tumorigenicity 1; DAN domain family member 1; Protein N03; Zinc finger protein DAN; | |
Q9Y6Z4 (KIAS1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein KIF25-AS1; KIF25 antisense RNA 1; KIF25 antisense gene protein 1; Protein HGC6.1; | |
Q9NVX2 (NLE1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Notchless protein homolog 1; | |
O43665 (RGS10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Regulator of G-protein signaling 10; | |
A0A1B0GTK4 (F237A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein FAM237A; | |
Q9BYR2 (KRA45_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Keratin-associated protein 4-5; Keratin-associated protein 4.5; Ultrahigh sulfur keratin-associated protein 4.5; | |
Q86UX6 (ST32C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein kinase 32C; PKE; Yet another novel kinase 3; | |
Q9NQ33 (ASCL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Achaete-scute homolog 3; Class A basic helix-loop-helix protein 42; bHLH transcriptional regulator Sgn-1; | |
O15229 (KMO_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Kynurenine 3-monooxygenase; Kynurenine 3-hydroxylase; | |
Q96CU9 (FXRD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | FAD-dependent oxidoreductase domain-containing protein 1; | |
Q8WVB3 (HEXD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Hexosaminidase D; Beta-N-acetylhexosaminidase; Beta-hexosaminidase D; Hexosaminidase domain-containing protein; N-acetyl-beta-galactosaminidase; | |
Q96RP7 (G3ST4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Galactose-3-O-sulfotransferase 4; Beta-galactose-3-O-sulfotransferase 4; Gal-beta-1,3-GalNAc 3'-sulfotransferase; | |
Q15172 (2A5A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform; PP2A B subunit isoform B'-alpha; PP2A B subunit isoform B56-alpha; PP2A B subunit isoform PR61-alpha; PP2A B subunit isoform R5-alpha; | |
Q9UNF0 (PACN2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein kinase C and casein kinase substrate in neurons protein 2; Syndapin-2; Syndapin-II; | |
Q9H1Z4 (WDR13_HUMAN) | Swiss-Prot | Homo sapiens (Human) | WD repeat-containing protein 13; | |
O43790 (KRT86_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Keratin, type II cuticular Hb6; Hair keratin K2.11; Keratin-86; Type II hair keratin Hb6; Type-II keratin Kb26; | |
P61204 (ARF3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor 3; | |
Q8NG06 (TRI58_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E3 ubiquitin-protein ligase TRIM58; Protein BIA2; RING-type E3 ubiquitin transferase TRIM58; Tripartite motif-containing protein 58; | |
Q9UNW1 (MINP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Multiple inositol polyphosphate phosphatase 1; 2,3-bisphosphoglycerate 3-phosphatase; | |
A1A4Y4 (IRGM_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunity-related GTPase family M protein; Immunity-related GTPase family M protein 1; Interferon-inducible protein 1; LPS-stimulated RAW 264.7 macrophage protein 47 homolog; | |
P0DPB3 (SCHI1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Schwannomin-interacting protein 1; | |
Q9Y2Y4 (ZBT32_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger and BTB domain-containing protein 32; FANCC-interacting protein; Fanconi anemia zinc finger protein; Testis zinc finger protein; Zinc finger protein 538; | |
Q96RI1 (NR1H4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Bile acid receptor; Farnesoid X-activated receptor; Farnesol receptor HRR-1; Nuclear receptor subfamily 1 group H member 4; Retinoid X receptor-interacting protein 14; | |
Q8N6W0 (CELF5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CUGBP Elav-like family member 5; Bruno-like protein 5; CUG-BP- and ETR-3-like factor 5; RNA-binding protein BRUNOL-5; | |
Q13043 (STK4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein kinase 4; Mammalian STE20-like protein kinase 1; STE20-like kinase MST1; Serine/threonine-protein kinase Krs-2; Serine/threonine-protein kinase 4 37kDa subunit; MST1/N; Serine/threonine-protein kinase 4 18kDa subunit; MST1/C; | |
Q3SY52 (ZIK1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein interacting with ribonucleoprotein K; Zinc finger protein 762; | |
Q9UMR2 (DD19B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ATP-dependent RNA helicase DDX19B; DEAD box RNA helicase DEAD5; DEAD box protein 19B; | |
P24046 (GBRR1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Gamma-aminobutyric acid receptor subunit rho-1; GABA(A) receptor subunit rho-1; GABA(C) receptor; | |
P09914 (IFIT1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Antiviral innate immune response effector IFIT1; Interferon-induced 56 kDa protein; Interferon-induced protein with tetratricopeptide repeats 1; | |
Q9UQ03 (COR2B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Coronin-2B; Coronin-like protein C; Protein FC96; | |
Q5VV17 (OTUD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | OTU domain-containing protein 1; DUBA-7; | |
Q8N9B8 (RGF1A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ras-GEF domain-containing family member 1A; | |
Q9H875 (PKRI1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PRKR-interacting protein 1; | |
Q05519 (SRS11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/arginine-rich splicing factor 11; Arginine-rich 54 kDa nuclear protein; Splicing factor, arginine/serine-rich 11; | |
P54284 (CACB3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Voltage-dependent L-type calcium channel subunit beta-3; Calcium channel voltage-dependent subunit beta 3; | |
P0CG40 (SP9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor Sp9; | |
O75354 (ENTP6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ectonucleoside triphosphate diphosphohydrolase 6; CD39 antigen-like 2; | |
P49759 (CLK1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Dual specificity protein kinase CLK1; CDC-like kinase 1; | |
P37287 (PIGA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phosphatidylinositol N-acetylglucosaminyltransferase subunit A; GlcNAc-PI synthesis protein; Phosphatidylinositol-glycan biosynthesis class A protein; | |
P30566 (PUR8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylosuccinate lyase; Adenylosuccinase; | |
P57764 (GSDMD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Gasdermin-D; Gasdermin domain-containing protein 1; Gasdermin-D, N-terminal; GSDMD-NT; hGSDMD-NTD; Gasdermin-D, C-terminal; GSDMD-CT; hGSDMD-CTD; Gasdermin-D, p13; Gasdermin-D, 13 kDa; 13 kDa GSDMD; Gasdermin-D, p40; | |
Q8TDL5 (BPIB1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | BPI fold-containing family B member 1; Long palate, lung and nasal epithelium carcinoma-associated protein 1; von Ebner minor salivary gland protein; | |
Q9UMX1 (SUFU_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Suppressor of fused homolog; | |
Q8N149 (LIRA2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Leukocyte immunoglobulin-like receptor subfamily A member 2; CD85 antigen-like family member H; Immunoglobulin-like transcript 1; Leukocyte immunoglobulin-like receptor 7; CD85h; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_03 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
20,663 | 17,634 | 43,400 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38,729 | 3,287 | 322 | 617 | 63 | 135 | 20 | 53 | 2 | 24 | 9 | 45 | 1 | 3 | 17 | 11 | 2 | 1 | 1 | 16 | 2 | 1 | 4 | 1 | 2 | 1 | 7 | 1 | 2 | 4 | 2 | 1 | 12 | 2 |